JP2018526352A5 - - Google Patents

Download PDF

Info

Publication number
JP2018526352A5
JP2018526352A5 JP2018506301A JP2018506301A JP2018526352A5 JP 2018526352 A5 JP2018526352 A5 JP 2018526352A5 JP 2018506301 A JP2018506301 A JP 2018506301A JP 2018506301 A JP2018506301 A JP 2018506301A JP 2018526352 A5 JP2018526352 A5 JP 2018526352A5
Authority
JP
Japan
Prior art keywords
group
alkyl
substituted
optionally
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018506301A
Other languages
English (en)
Japanese (ja)
Other versions
JP6816107B2 (ja
JP2018526352A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/068291 external-priority patent/WO2017025368A1/en
Publication of JP2018526352A publication Critical patent/JP2018526352A/ja
Publication of JP2018526352A5 publication Critical patent/JP2018526352A5/ja
Application granted granted Critical
Publication of JP6816107B2 publication Critical patent/JP6816107B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018506301A 2015-08-07 2016-08-01 インダニルアミノピリジルシクロプロパンカルボン酸、医薬組成物及びこれらの使用 Expired - Fee Related JP6816107B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP15180175.0 2015-08-07
EP15180175 2015-08-07
EP15199739 2015-12-14
EP15199739.2 2015-12-14
PCT/EP2016/068291 WO2017025368A1 (en) 2015-08-07 2016-08-01 Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof

Publications (3)

Publication Number Publication Date
JP2018526352A JP2018526352A (ja) 2018-09-13
JP2018526352A5 true JP2018526352A5 (enExample) 2020-11-05
JP6816107B2 JP6816107B2 (ja) 2021-01-20

Family

ID=56618142

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018506301A Expired - Fee Related JP6816107B2 (ja) 2015-08-07 2016-08-01 インダニルアミノピリジルシクロプロパンカルボン酸、医薬組成物及びこれらの使用

Country Status (4)

Country Link
US (1) US9617251B2 (enExample)
EP (1) EP3331860B1 (enExample)
JP (1) JP6816107B2 (enExample)
WO (1) WO2017025368A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3544958B1 (en) * 2016-11-28 2021-03-24 Boehringer Ingelheim International GmbH Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
JP6968181B2 (ja) * 2017-01-26 2021-11-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング インダニルアミノピラジニルシクロプロパンカルボン酸、その医薬組成物及び使用
JOP20180040A1 (ar) * 2017-04-20 2019-01-30 Gilead Sciences Inc مثبطات pd-1/pd-l1
JP7062792B2 (ja) 2018-02-13 2022-05-06 ギリアード サイエンシーズ, インコーポレイテッド Pd-1/pd-l1阻害剤
US10568874B2 (en) 2018-02-22 2020-02-25 Chemocentryx, Inc. Indane-amines as PD-L1 antagonists
CA3093851A1 (en) 2018-03-29 2019-10-03 Arbutus Biopharma Corporation Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using same
EP3781556B1 (en) 2018-04-19 2025-06-18 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
CN118221646A (zh) 2018-07-13 2024-06-21 吉利德科学公司 Pd-1/pd-l1抑制剂
KR102291885B1 (ko) * 2018-10-10 2021-08-23 한국생명공학연구원 카벤 화합물, 카벤-금속나노입자 복합체 및 이의 제조방법
KR102635333B1 (ko) 2018-10-24 2024-02-15 길리애드 사이언시즈, 인코포레이티드 Pd-1/pd-l1 억제제
JP2022552655A (ja) 2019-10-07 2022-12-19 キャリーオペ,インク. Gpr119アゴニスト
PH12022552277A1 (en) 2020-02-28 2024-03-04 Kallyope Inc Gpr40 agonists
CA3178994A1 (en) 2020-05-19 2021-11-25 Iyassu Sebhat Ampk activators
JP2023531726A (ja) 2020-06-26 2023-07-25 キャリーオペ,インク. Ampkアクチベーター

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960369B2 (en) 2002-11-08 2011-06-14 Takeda Pharmaceutical Company Limited Receptor function regulator
EP1726580A4 (en) 2004-03-15 2008-02-13 Takeda Pharmaceutical AMINOPHNYLPROPANO ACID DERIVATIVE
AU2006291234A1 (en) 2005-09-14 2007-03-22 Amgen Inc. Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
US8633182B2 (en) 2012-05-30 2014-01-21 Boehringer Ingelheim International Gmbh Indanyloxyphenylcyclopropanecarboxylic acids
EP3036237A4 (en) * 2013-08-23 2017-01-25 Fujian Haixi Pharmaceuticals Co. Ltd Carboxylic acid compounds in treatment of diabetes mellitus

Similar Documents

Publication Publication Date Title
JP2018526352A5 (enExample)
JP2018526405A5 (enExample)
JP2020505393A5 (enExample)
JP2020505400A5 (enExample)
JP2019535792A5 (enExample)
JP2020505394A5 (enExample)
JP2020514315A5 (enExample)
JP2020506205A5 (enExample)
RU2403258C2 (ru) Тиазолилдигидроиндазолы
JP2019532110A5 (enExample)
CN113272301A (zh) 杂环类化合物、中间体、其制备方法及应用
CL2020000363A1 (es) Inhibidores macrocíclicos de mcl-1 y métodos de uso.
JP2019504050A5 (enExample)
EP4458348A3 (en) Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof
JP2015504081A5 (enExample)
JP2021504317A5 (enExample)
IL274229B2 (en) Antibacterial compounds
JP2017511360A5 (enExample)
HRP20120696T1 (hr) Spiro-prstenasti spoj i njegova medicinska upotreba
JP2015516427A5 (enExample)
RU2019130519A (ru) 4-пиридоновое соединение или его соль, фармацевтическая композиция и содержащий их состав
JP2016534084A5 (enExample)
MX2020014116A (es) Agente profilactico o terapeutico para atrofia muscular espinal.
RU2016134749A (ru) Гетероциклическое сульфонамидное производное и лекарственное средство, содержащее такое производное
JP2015537017A5 (enExample)